White matter hyperintensities on t2-weighted MRI images among dna-verified older familial hypercholesterolemia patients

Acta Radiologica

Volumn 50, Issue 3, 2009, Pages 320-326

  Hyttinen, L ^a   Autti, T ^b   Rauma, S ^a   Soljanlahti, S ^b   Vuorio, A F ^c   Strandberg, T E ^d,e  

^a NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adults; Arteriosclerosis; CNS; Familial hypercholesterolemia; Magnetic resonance imaging; White matter hyperintensity

Indexed keywords

ADULTS; ARTERIOSCLEROSIS; CNS; FAMILIAL HYPERCHOLESTEROLEMIA; WHITE MATTER HYPERINTENSITY;

MAGNETIC RESONANCE IMAGING; NUCLEIC ACIDS;

MAGNETIC RESONANCE;

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN RECEPTOR;

AGE; AGED; ARTICLE; BRAIN; BRAIN INFARCTION; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; GENETICS; HETEROZYGOTE DETECTION; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; IMAGE PROCESSING; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REFERENCE VALUE;

AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN; CEREBRAL INFARCTION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HETEROZYGOTE DETECTION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RECEPTORS, LDL; REFERENCE VALUES;

EID: 64149093282     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850802709227     Document Type: Article

References (23)

1. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, editors. The metabolic and molecular bases ofinherited disease. Eighth ed. New York: McGraw-Hill Book Co; 2001. p. 2863-913.
2. Scientific Steering Committee on behalfofthe Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolemia: implications for clinical management. Atherosclerosis 1999;142:105-12.
3. Gerdes VEA, Kwa VIH, ten Cate H, Brandjes DPM, Buller HR, Stam J. Cerebral white matter lesions predict both ischemic strokes and myocardial infarctions in patients with established atherosclerotic disease. Atherosclerosis 2006;186:166-72.
4. Kuller LH, Longstreth WT Jr, Arnold AM, Bernick C, Bryan RN, Beauchamp NJ Jr. Cardiovascular Health Study Collaborative Research Group. White matter hyperintensity on cranial magnetic resonance imaging: a predictor ofstroke. Stroke 2004;35:1821-5.
5. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MMB. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003;34: 1126-9.
6. Pantoni L, Garcia JH. Pathogenesis ofleukoaraiosis: a review. Stroke 1997;28:652-9.
7. Autti T, Raininko R, Vanhanen SL, Kallio M, Santavuori P. MRI ofthe normal brain from early childhood to middle age. I. Appearances on T2- and proton density-weighted images and occurrence ofincidental high-signal foci. Neuroradiology 1994;36:644-8.
8. Salonen O, Autti T, Raininko R, Ylikoski A, Erkinjuntti T. MRI ofthe brain in neurologically healthy middle-aged and elderly individuals. Neuroradiology 1997;39: 537-45.
9. Soljanlahti S, Autti T, Lauerma K, Raininko R, Keto P, Turtola H, et al. Familial hypercholesterolemia patients treated with statins at no increased risk for intracranial vascular lesions despite increased cholesterol burden and extracranial atherosclerosis. Stroke 2005;36:1572-4.
10. Soljanlahti S, Raininko R, Hyttinen L, Lauerma K, Keto P, Vuorio AF, et al. Statin-treated familial hypercholesterolemia patients with coronary heart disease and pronounced atherosclerosis do not have more brain lesions than healthy controls in later middle age. Acta Radiol 2007;48:894-9.
11. Schmitz SA, O'Regan DP, Fitzpatrick J, Neuwirth C, Potter E, Tosi I, et al. White matter brain lesions in midlife familial hypercholesterolemic patients at 3-Tesla magnetic resonance imaging. Acta Radiol 2008;49: 184-9.
12. Vuorio AF, Turtola H, Piilahti K-M, Repo P, Kanninen T, Kontula K. Familial hypercholesterolemia in the Finnish North Karelia. A molecular, clinical and genealogical study. Arterioscler Thromb Vasc Biol 1997; 17:3127-38.
13. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, et al., Cardiovascular Health Study Collaborative Research Group. Clinical correlates ofwhite matter findings on cranial magnetic resonance imaging of3301 elderly people. The Cardiovascular Health Study. Stroke 1996;27:1274-82.
14. de Leeuw F-E, de Groot JC, Achten E, Oudkerk M, Ramos LMP, Heijboer R, et al. Prevalence ofcerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001; 70:9-14.
15. Murray AD, Staff RT, Shenkin SD, Deary IJ, Starr JM, Whalley LJ. Brain white matter hyperintensities: relative importance ofvascular risk factors in nondemented elderly people. Radiology 2005;237:251-7.
16. Liao D, Cooper L, Cai J, Toole J, Bryan N, Burke G, et al. The prevalence and severity ofwhite matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology 1997;16:149-62.
17. Vernooij MW, Ikram MA, Tanghe HL, Vincent AJPE, Hofman A, Krestin GP, et al. Incidental findings on brain MRI in the general population. N Engl J Med 2007;357:1821-8.
18. Giele JLP, Witkamp TD, Mali WPTM, van der Graaf Y, for the SMART Study Group. Silent brain infarcts in patients with manifest vascular disease. Stroke 2004;35: 742-6.
19. Price TR, Manolio TA, Kronmal RA, Kittner SJ, Yue NC, Robbins J, et al., for the CHS Collaborative Research Group. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults: the Cardiovascular Health Study. Stroke 1997;28:1158-64.
20. Miida T, Takahashi A, Ikeuchi T. Prevention ofstroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects. Pharmacol Ther 2007;113:378-93.
21. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and metaanalysis. Br Med J 2003;326:1423-9.
22. Kaste M, Koivisto P. Risk of brain infarction in familial hypercholesterolemia. Stroke 1988;19:1097-100.
23. Vaughan CJ, Delanty N, Basson CT. Statin therapy and stroke prevention. Curr Opin Cardiol 2001;16:219-24.